✦ LIBER ✦

Outcome of patients with acute myelogenous leukemia after second salvage therapy

✍ Scribed by Francis Giles; Susan O'Brien; Jorge Cortes; Srdan Verstovsek; Carlos Bueso-Ramos; Jianqin Shan; Sherry Pierce; Guillermo Garcia-Manero; Michael Keating; Hagop Kantarjian

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 203 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of adults with acute lymphocytic

Outcome of adults with acute lymphocytic leukemia after second salvage therapy

✍ Susan O'Brien; Deborah Thomas; Farhad Ravandi; Stefan Faderl; Jorge Cortes; Gaut 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Relationship between patients' age, bone

Relationship between patients' age, bone marrow karyotype, and outcome of induction therapy in acute myelogenous leukemia

✍ Dr. Ph. Bernard; F. Lacombe; J. Reiffers; B. David; G. Marit; M. J. Bourdeau; A. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

Bone marrow karyotypes were performed in 88 cases of adult acute myelogenous leukemia (AML) at diagnosis and classified NN (normal), AA (abnormal), and AN (mixture of normal and abnormal metaphases). A clear relationship was found between karyotype and complete remission (CR) rate: 58% CR in (NN + A

Increasing dose intensity of anthracycli

Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia

✍ N. Novitzky; V. Thomas; L. Abrahams; C. du Toit; A. McDonald 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

## Abstract To understand the effect of dose concentration in the overall survival of AML, we conducted a study on the efficacy and toxicity of a drug combination where the dose of daunorubicin was intensified. For this analysis, the outcome of patients entered into two consecutive prospective tria

Predictors and outcome of acute kidney i

Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome

✍ Amit Lahoti; Hagop Kantarjian; Abdulla K. Salahudeen; Farhad Ravandi; Jorge E. C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

Financial analysis of patients with newl

Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy

✍ Ellin Berman; Claudia Little; Bonnie Teschendorf; Meaghan Jones; Glenn Heller 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Background: Medicare and third-party payers may be reluctant to pay for investigational (protocol) therapy for patients with cancer on the premise that such treatment is more expensive than standard therapy. however, prior studies that have attempted to compare protocol therapy with standard the

Granulocytic sarcoma of the ovary in pat

Granulocytic sarcoma of the ovary in patients with acute myelogenous leukemia

✍ Kou Yamamoto; Dr. Hideki Akiyama; Tamotsu Maruyama; Hisashi Sakamaki; Yasusuke O 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 2 views